GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Cash Receipts from Fees and Commissions

Argenica Therapeutics (ASX:AGN) Cash Receipts from Fees and Commissions


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applies to banks.


Argenica Therapeutics (ASX:AGN) Business Description

Industry
Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.